Medical - Healthcare Plans · NYSE
Current Price
$194.45
PE Ratio (TTM)
1215.3x
Intrinsic Value
Use the calculator below to estimate
COMPETITIVE MOAT
↑Government Contract Expertise
Molina excels in navigating complex government contracts for Medicaid and Medicare. This deep understanding creates high barriers to entry for competitors.
↑Member Relationships and Trust
Strong, long-standing relationships with vulnerable member populations foster loyalty. This trust is difficult for new entrants to replicate quickly.
↑Scale in Niche Markets
Molina's significant scale within specific, often underserved, geographic and demographic markets provides operational efficiencies. This scale is hard for smaller players to match.
INVESTMENT RISKS
↓Dependence on Government Programs
Molina's heavy reliance on Medicare and Medicaid programs makes it highly susceptible to government funding decisions and regulatory changes.
↓Execution Risk in Acquisitions
The company has grown through acquisitions, which carry inherent risks of integration challenges and failure to achieve expected synergies.
↓Operational Complexity
Managing diverse member needs and complex government regulations across multiple states presents significant operational challenges and potential for errors.
Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Molina Healthcare, Inc. respond.
Open PE Calculator for MOHMolina Healthcare, Inc. offers comprehensive managed health care services, primarily targeting economically disadvantaged families and individuals. The company provides coverage through key government initiatives such as Medicaid and Medicare programs, in addition to state health insurance marketplaces. Its operations are strategically segmented into four main divisions: Medicaid, Medicare, Marketplace, and a general "Other" category. By the close of 2021, specifically December 31st, Molina Healthcare's network extended to approximately 5.2 million members across 18 states, all of whom qualified for Medicaid, Medicare, or other government-sponsored healthcare plans. Established in 1980, the company maintains its corporate headquarters in Long Beach, California.
PE Ratio (TTM)
1215.3x
PEG Ratio
n/m
Earnings Yield
-0.07%
ROE (TTM)
-0.2%
Revenue/Share (TTM)
$867.88
Debt/Equity
0.95x
The trailing twelve-month PE ratio of MOH reflects how much investors pay per dollar of Molina Healthcare, Inc.'s earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.
MOH's PE of 1215.3x combined with a PEG ratio of -12.25 provides a growth-adjusted perspective. MOH has negative earnings, so its PE and PEG ratios are not meaningful here and cannot tell you whether the stock is over or undervalued. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.
To value Molina Healthcare, Inc. using PE: (1) Compare the current PE (1215.3x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (-12.25) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.
MOH's PEG ratio is -12.25, calculated by dividing the PE ratio (1215.3x) by the expected earnings growth rate. Because MOH has negative earnings, its PEG ratio is not meaningful and should not be read as a sign of under or overvaluation. Note that PEG accuracy depends on the reliability of growth estimates.
PE ratio gives a quick relative read — how MOH is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.
P/E and DCF value MOH with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.
Price as of 2026-07-30. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.
This is an estimate, not investment advice.